Bianchi Porro G, Parente F
Gastrointestinal Unit, L. Sacco Hospital, Milan, Italy.
Drugs. 1991 Jan;41(1):38-51. doi: 10.2165/00003495-199141010-00004.
Duodenal ulcer is a chronic disease characterised by remission and relapses. The duration of this relapsing tendency is unpredictable for the individual patient, but in most cases it lasts for many years and perhaps the entire lifetime. Various therapeutic strategies have been suggested to maintain the disease in remission: continuous, intermittent and on-demand treatment with H2-antagonists, or surgery. Continuous maintenance treatment with the currently available H2-blockers has proved to be superior to all the other strategies in terms of efficacy, and should therefore be regarded as the long term treatment of choice for duodenal ulcer patients. The duration of maintenance treatment is still uncertain, but probably it should not be less than a few years. Intermittent treatment or surgery could be proposed to patients unsuitable for continuous maintenance, depending on whether they have mild or aggressive disease, respectively.
十二指肠溃疡是一种具有缓解和复发特征的慢性疾病。对于个体患者而言,这种复发倾向的持续时间是不可预测的,但在大多数情况下会持续多年,甚至可能终生。为使疾病维持缓解状态,人们提出了各种治疗策略:使用H2拮抗剂进行持续、间歇和按需治疗,或进行手术。就疗效而言,使用目前可用的H2阻滞剂进行持续维持治疗已被证明优于所有其他策略,因此应被视为十二指肠溃疡患者的长期首选治疗方法。维持治疗的持续时间仍不确定,但可能不应少于数年。对于不适合持续维持治疗的患者,可根据其病情是轻度还是侵袭性,分别建议采用间歇治疗或手术。